Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.
about
DTI and Myelin Plasticity in Bipolar Disorder: Integrating Neuroimaging and Neuropathological FindingsToxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological DisordersMolecular substrates of schizophrenia: homeostatic signaling to connectivityPre-clinical models of neurodevelopmental disorders: focus on the cerebellumWhite matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease.Myelination, oligodendrocytes, and serious mental illness.Early postnatal in vivo gliogenesis from nestin-lineage progenitors requires cdk5The mechanism of Naringin-enhanced remyelination after spinal cord injury.Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder.Deep white matter in Huntington's diseaseA critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.White matter alterations in bipolar disorder: potential for drug discovery and development.Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder.Indirect association of DAT1 genotype with executive function through white matter volume in orbitofrontal cortex.Physical Exercise Keeps the Brain Connected: Biking Increases White Matter Integrity in Patients With Schizophrenia and Healthy ControlsmiR-149 and miR-29c as candidates for bipolar disorder biomarkers.Diversity Matters: A Revised Guide to Myelination.Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy ControlsImpact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockadeMicrostructural white-matter abnormalities and their relationship with cognitive dysfunction in obsessive-compulsive disorder.Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases.White matter tract integrity of anterior limb of internal capsule in major depression and type 2 diabetes.Acute nicotine administration effects on fractional anisotropy of cerebral white matter and associated attention performanceWhite matter integrity as a predictor of response to treatment in first episode psychosis.Wnt and lithium: a common destiny in the therapy of nervous system pathologies?On the role of the extracellular space on the holistic behavior of the brain.Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.The Effects of Prenatal Iron Deficiency and Risperidone Treatment on the Rat Frontal Cortex: A Proteomic Analysis.Altering the course of schizophrenia: progress and perspectives.White-matter connectivity related to paliperidone treatment response in patients with schizophrenia.Role of Dopamine D2 Receptor in Stress-Induced Myelin LossThe neurobiology of transition to psychosis: clearing the cache.Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia.State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis.Changes in white matter microstructure predict lithium response in adolescents with bipolar disorder.Adverse childhood experiences influence white matter microstructure in patients with bipolar disorder.Acute oligodendrocyte loss with persistent white matter injury in a third trimester equivalent mouse model of fetal alcohol spectrum disorder.Characterization of white matter abnormalities in early-stage schizophrenia.Clozapine influences cytoskeleton structure and calcium homeostasis in rat cerebral cortex and has a different proteomic profile than risperidone.
P2860
Q26765967-F6B2F82F-4D26-4A95-98F2-B56223121465Q28709645-350C209C-9E90-4DCA-AE85-7AB0A7842ACAQ30383611-7FD76D8A-6DAF-424B-A745-5A547A5F39B9Q30436913-13656FD9-E4F9-4867-A0A3-F6EA401063C3Q30711356-3E8EF397-F935-4629-B174-8A9A304610FBQ30838265-5CB18593-4953-4A09-9C2B-11298D112AB6Q31133336-A3CD82EF-56BA-4EE1-93C4-A9A248CD2867Q33588579-03639CE7-A622-45EE-A0D8-83EA2B7DF666Q34111775-2ABE9BB8-85DB-469C-BA2C-A9309EB9AFEBQ34394979-A69BFBA5-A0B7-4BBA-9DE8-7BEF62F63A40Q34405264-248CEBA6-BA0E-4E27-A96C-5A220A580A0CQ34406905-9E2EC1C4-C3E3-48FB-8C81-BD94CB7A1431Q35217858-AE249135-63A8-4EE3-B4D6-7F2252C829F1Q35498962-AC8CA895-B847-49B3-B8F7-5499C9D310ABQ35739019-3CD9201C-D12D-42E9-8258-5399873C8939Q36278042-E92E9271-5577-45D5-8129-FF1C70B046C7Q36505475-D221C05C-CA5E-488D-8AC5-CB03C8BFB1B6Q36580009-537D9970-1864-4DC3-9195-653A304A251FQ36597061-8501F8DF-F7E8-41AB-A82F-9A5EDB9FC419Q36609798-A85F7A7A-B544-4F16-BEB0-E0B16E4ADC32Q36797625-B97E96EB-8781-445B-9C09-A3B45453380FQ36798870-986E4DA8-A819-430A-B10C-F1889E11423DQ36927723-034EC357-2CA3-4225-B921-51B6B92CF6ECQ37180050-B3802CDB-2561-4F39-9EDD-3BFB4E36B799Q37477310-AE351889-B9F2-4E39-845E-C1F167C52C01Q38113139-6EC0AFB9-96D0-4409-BD5E-1A6BC6CCB308Q38535579-AB417E61-A4C6-4E4E-AF63-88A4D2F52B50Q38538932-758A1977-55D2-4815-A050-8EBA115CD808Q38648807-0F41206A-799A-451A-99DC-5B0C55DA14FEQ38759421-234F4DBD-882C-4EB8-B6A6-DB2A570B13F7Q40119382-95181C34-D02F-4752-9DE2-AF48B2706C7EQ41050402-2C6026AA-79F0-4521-86F5-5A3AF5BD504DQ41535826-3C64BB98-2000-40A1-9243-88DCDA73FAC5Q46762632-3F5036B4-DA06-4AC7-AA4D-033EFC35DF9EQ47301729-988E6D57-45CE-4A41-AA52-7C4F40D82724Q47745367-BEA4102C-CF3B-4E78-8EE9-0FE557DE74FEQ47840640-64DCD02E-C123-43FF-905F-7B83CA14D339Q48127275-800837CE-3684-4AAD-8D1B-B89CA824CDD3Q48358415-5763E3D6-27CF-4CD7-945A-312BDA70F417Q48423771-BA4DE944-F0D2-4A41-A0D3-8E3A83277C9C
P2860
Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neuroglialpharmacology: myelin ...... on of psychotropic treatments.
@en
Neuroglialpharmacology: myelin ...... on of psychotropic treatments.
@nl
type
label
Neuroglialpharmacology: myelin ...... on of psychotropic treatments.
@en
Neuroglialpharmacology: myelin ...... on of psychotropic treatments.
@nl
prefLabel
Neuroglialpharmacology: myelin ...... on of psychotropic treatments.
@en
Neuroglialpharmacology: myelin ...... on of psychotropic treatments.
@nl
P2860
P1433
P1476
Neuroglialpharmacology: myelin ...... on of psychotropic treatments.
@en
P2093
George Bartzokis
P2860
P304
P356
10.1016/J.NEUROPHARM.2012.01.015
P577
2012-01-28T00:00:00Z